SQZ Biotechnologies Company (SQZB)

Market Cap	707.79K +4.3%
Revenue (ttm)	12.12M -44.6%
Net Income	-71.64M
EPS	-2.43
Shares Out	29.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,648
Open	0.0100
Previous Close	n/a
Day's Range	0.0100 - 0.0240
52-Week Range	0.0100 - 0.0500
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SQZB

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, infectious diseases, and other serious conditions in Massachusetts. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 53
• Stock Exchange: OTCMKTS
• Ticker Symbol: SQZB

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 26, 2026

Data Sources Report a data error